| Publication Date | Title | Author(s) |
| Jan-2021 | COVID-19 living evidence profile #1 (version 1.2): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Feb-2021 | COVID-19 living evidence profile #1 (version 1.3): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Feb-2021 | COVID-19 living evidence profile #1 (version 1.4): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Mar-2021 | COVID-19 living evidence profile #1 (version 1.5): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Mar-2021 | COVID-19 living evidence profile #2 (version 2.2): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes? | Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN |
| Apr-2021 | COVID-19 living evidence profile #2 (version 2.3): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes? | Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN |
| Jul-2021 | COVID-19 living evidence profile #2 (version 2.4): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes? | Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN |
| Oct-2020 | COVID-19 rapid evidence profile #22: What is known about whether vaccine injury-compensation programs and program elements affect vaccine acceptance and uptake? | Bhuiya, AR; Waddell, K; Moat, KA; Wilson, MG; Gauvin, François-Pierre; Whitelaw, S; Alam, S; Sharma, K; Drakos, A; Lavis, JN |
| Nov-2020 | COVID-19 rapid evidence profile #23: What is known about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations? | Bhuiya, AR; Wilson, MG; Moat, KA; Gauvin, François-Pierre; Wang, Q; Whitelaw, S; Alam, S; Sharma, K; Ahmad, A; Drakos, A; Dren, N; Bain, T; Lavis, JN |
| Jan-2021 | COVID-19 rapid evidence profile #25: What do we know from both research and jurisdictional scans about prioritizing vaccination of asymptomatic residents in a long-term care home with an outbreak? | Wang, Q; Wilson, MG; Alam, S; Ahmad, A; Bain, T; Bhuiya, AR; Drakos, A; Sharma, K; Whitelaw, S; Bain, T; Lavis, JN |
| Mar-2021 | COVID-19 rapid evidence profile #26: When and in what order can COVID-19-related public-health measures be lifted (or stringency be reduced) as vaccination rates and seasonal temperatures increase? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Sharma, K; Whitelaw, S; Lavis, JN |
